Longenesis - Hong-Kong based company which offers industry's the most advanced life data escrow built on Exonum™ blockchain for security and powered with AI for traceability and smart data management.
longenesis logo

    • Leader in Artificial Intelligence for Drug Discovery, Biomarker Development and Aging Research
    • Attracted over $12 million in venture funding
    • NVIDIA's top 5 AI Companies for Social Impact
    • Over 200 research collaborators worldwide
    • Deals with big pharma companies
    • Over 40 peer-reviewed research publications
    • Executed Projects: Young.AI, Embryonic.AI,, Chemistry.AI,

    • The world's leading full-service blockchain technology company
    • Architect of the open-source blockchain framework Exonum
    • Bitcoin transaction processer, with datacenters in Georgia, Iceland, Canada and Norway
    • Leading several blockchain projects around the world, including the Republic of Georgia, Ukraine, Bermuda and Malta
    • More than $100 million in venture in debt and equity
    Baltimore, USA
    Amsterdam, Netherlands
    was formed as a result of two large companies partnership. Insilico Medicine represents the Artificial Intelligence. Bitfury Group provides Exonum blockchain solution.

    Just by submitting information and regularly contributing data to Longenesis, users could sell their data to pharma companies. This on will create a healthy circulation of life data.
    Sell your health data
    Use Case
    Our goal is to build a revolutionary platform that delivers the future of medicine and data analytics through integration best AI and Blockchain solution available.
    By building and launching this platform on blockchain technology, we can assure our users that their files are private and secure. Users can store and track their medical data to gain insight into their health like never before.
    Securely store data and track your health
    Utilizing smart contracts to give the buyer and seller a direct line of communication in a secure manner. Buyers can send data requests to Sellers without having to go through a human intermediary so the process can be streamlined. This allows buyers and sellers to communicate directly in a secure setting.
    Direct interaction without third parties
    Longenesis data escrow will be able to provide new insights in the fields of Healthcare R&D. It will provide analysis and recommendations to pharmaceutical companies to help developing new drugs.
    Healthcare Development
    Nebula Genomics powered by Longenesis
    Application of artificial intelligence and blockchain technology creating a marketplace for individuals and biobanks to store, manage, and control access to genomic and other health data in a secure environment.
    New York, USA
    Alex Zhavoronkov, CSO, Longenesis
    Consensus 2018
    Singularity Exponential Medicine 2017
    South Korea
    San Diego, USA
    The Global Leaders Forum
    Alex Zhavoronkov, CEO, Insilico Medicine

    Valery Vavilov, Founder and CEO, Director of the Board, Bitfury
    Emil Syndyukov, CTO, Longenesis
    Malta Blockchain Summit 2018
    Contact us
    © 2018. All Rights Reserved. Longenesis Ltd.